A

AcelRx Pharmaceuticals Inc
F:R5X

Watchlist Manager
AcelRx Pharmaceuticals Inc
F:R5X
Watchlist
Price: 2.106 EUR 9.74% Market Closed
Market Cap: 310.3m EUR

Intrinsic Value

R5X price has not been updated for more than 1 month. This may indicate that the stock has been delisted.
R5X doesn't have a meaningful market cap.

There is not enough data to reliably calculate the intrinsic value of R5X.

The Intrinsic Value is calculated as the average of DCF and Relative values:

R5X Intrinsic Value
Not Available
Base Case Scenario
Compare R5X to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about R5X?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
AcelRx Pharmaceuticals Inc

Current Assets 14.4m
Cash & Short-Term Investments 13.4m
Other Current Assets 1m
Non-Current Assets 8.9m
Intangibles 8.8m
Other Non-Current Assets 100k
Current Liabilities 3.6m
Accounts Payable 1m
Accrued Liabilities 1.8m
Other Current Liabilities 800k
Non-Current Liabilities 1.4m
Other Non-Current Liabilities 1.4m
Efficiency

Free Cash Flow Analysis
AcelRx Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
AcelRx Pharmaceuticals Inc

Revenue
620k USD
Operating Expenses
-20.6m USD
Operating Income
-20m USD
Other Expenses
-6.5m USD
Net Income
-26.5m USD
Fundamental Scores

R5X Profitability Score
Profitability Due Diligence

AcelRx Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ROE is Increasing
Strong 3Y Average Net Margin
Low Gross Margin
Negative 3Y Average Gross Margin
hidden
Profitability
Score

AcelRx Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

R5X Solvency Score
Solvency Due Diligence

AcelRx Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
hidden
Solvency
Score

AcelRx Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

R5X Price Targets Summary
AcelRx Pharmaceuticals Inc

There are no price targets for R5X.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for R5X is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y